Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial. [electronic resource]
Producer: 20131022Description: e61160 p. digitalISSN:- 1932-6203
- Abdominal Fat -- drug effects
- Blood Glucose -- metabolism
- Body Composition -- drug effects
- Double-Blind Method
- Female
- Glucose Tolerance Test
- HIV Infections -- drug therapy
- Homeostasis
- Human Growth Hormone -- adverse effects
- Humans
- Insulin Resistance
- Insulin-Like Growth Factor I -- metabolism
- Lipid Metabolism -- drug effects
- Male
- Middle Aged
- Placebos
- Recombinant Proteins -- pharmacology
- Rosiglitazone
- Thiazolidinediones -- adverse effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.